CBAY Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Events Timeline

No data

News

5.0

2025-04-10Newsfilter

Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens

-.-

2024-04-25Investing.com

Gilead posts quarterly loss on acquisition charge, revenue rises 5% By Reuters

-.-

2024-03-22SeekingAlpha

Gilead completes CymaBay acquisition but negative impact on 2024 EPS

-.-

2024-03-21NASDAQ.COM

Guru Fundamental Report for CBAY

-.-

2024-03-11NASDAQ.COM

Gilead Sciences Announces Expiration Of HSR Waiting Period For CymaBay Tender Offer

-.-

2024-02-22NASDAQ.COM

Guru Fundamental Report for CBAY

0 Analyst Rating

Wall Street analysts forecast CBAY stock price to rise

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

Cantor Fitzgerald

Carter Gould

Buy

Initiates

$125

AI Analysis

2025-04-22

Reason

Cantor Fitzgerald

Carter Gould

Price Target

$125

AI Analysis

2025-04-22

Initiates

Buy

Reason

Valuation Metrics

The current forward P/E ratio for CymaBay Therapeutics Inc (CBAY.O) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess CymaBay Therapeutics Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

Current PE

NaN

Overvalued PE

Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

Current EV/EBITDA

NaN

Overvalued EV/EBITDA

Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

Current PS

NaN

Overvalued PS

Undervalued PS

Financials

AI Analysis

Annual

Quarterly

Whales Holding CBAY

Trading Trends

People Also Watch

Frequently Asked Questions

What is CymaBay Therapeutics Inc (CBAY) stock price today?

The current price of CBAY is 0 USD — it has increased 0

What is CymaBay Therapeutics Inc (CBAY)'s business?

What is the price predicton of CBAY Stock?

Wall Street analysts forecast CBAY stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CBAY is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CymaBay Therapeutics Inc (CBAY)'s revenue for the last quarter?

CymaBay Therapeutics Inc revenue for the last quarter amounts to NaN USD, decreased

What is CymaBay Therapeutics Inc (CBAY)'s earnings per share (EPS) for the last quarter?

CymaBay Therapeutics Inc. EPS for the last quarter amounts to USD, decreased

How many employees does CymaBay Therapeutics Inc (CBAY). have?

CymaBay Therapeutics Inc (CBAY) has 0 emplpoyees as of April 04 2026.

What is CymaBay Therapeutics Inc (CBAY) market cap?

Today CBAY has the market capitalization of 0.00 USD.

CBAY Overview

CBAY Overview

Events Timeline

No data

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Whales Holding CBAY

Trading Trends

People Also Watch

Frequently Asked Questions

What is CymaBay Therapeutics Inc (CBAY) stock price today?

What is CymaBay Therapeutics Inc (CBAY)'s business?

What is the price predicton of CBAY Stock?

What is CymaBay Therapeutics Inc (CBAY)'s revenue for the last quarter?

What is CymaBay Therapeutics Inc (CBAY)'s earnings per share (EPS) for the last quarter?

How many employees does CymaBay Therapeutics Inc (CBAY). have?

What is CymaBay Therapeutics Inc (CBAY) market cap?